These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7703379)

  • 1. Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo.
    Akalin E; Hancock WW; Perico N; Remuzzi G; Imberti O; Carpenter CB; Sayegh MH
    J Am Soc Nephrol; 1995 Jan; 5(7):1418-25. PubMed ID: 7703379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH; Akalin E; Hancock WW; Russell ME; Carpenter CB; Linsley PS; Turka LA
    J Exp Med; 1995 May; 181(5):1869-74. PubMed ID: 7536798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine allows prolonged survival of highly reactive renal allograft in the rat.
    Ostermann D; Perico N; Imberti O; Barbui C; Bontempelli M; Remuzzi G
    J Am Soc Nephrol; 1993 Dec; 4(6):1294-9. PubMed ID: 8130355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
    Perico N; Ostermann D; Bontempeill M; Morigi M; Amuchastegui CS; Zoja C; Akalin E; Sayegh MH; Remuzzi G
    J Am Soc Nephrol; 1996 Apr; 7(4):594-601. PubMed ID: 8724893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen.
    Sayegh MH; Zhang ZJ; Hancock WW; Kwok CA; Carpenter CB; Weiner HL
    Transplantation; 1992 Jan; 53(1):163-6. PubMed ID: 1733066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
    Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the rat.
    Sayegh MH; Kut JP; Milford EL
    Hum Immunol; 1989 Oct; 26(2):131-6. PubMed ID: 2531130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
    Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.
    Welling TH; Lu G; Csencsits K; Wood SC; Jarvinen L; Bishop DK
    Surgery; 2008 Mar; 143(3):394-403. PubMed ID: 18291261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat].
    Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory cell-mediated tolerance does not protect against chronic rejection.
    Koshiba T; Kitade H; Van Damme B; Giulietti A; Overbergh L; Mathieu C; Waer M; Pirenne J
    Transplantation; 2003 Aug; 76(3):588-96. PubMed ID: 12923449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
    Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL
    Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of TH1 functions during the regulation phase of mercury disease in brown Norway rats.
    Castedo M; Pelletier L; Pasquier R; Druet P
    Scand J Immunol; 1994 Feb; 39(2):144-50. PubMed ID: 7905205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.